FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997862810> ?p ?o ?g. }

• W2997862810 endingPage "56" @default.
• W2997862810 startingPage "56" @default.
• W2997862810 abstract "Oral squamous cell carcinoma (OSCC) is among the most commonly diagnosed malignancies in the world. Patients with OSCC often develop treatment resistance, resulting in a poor prognosis. Mounting evidence indicates that interactions between cancerous cells and other components of the tumor microenvironment (TME) determine their response to treatment. Herein, we examined the role of cancer stem cell-derived extracellular vesicles (CSC_EVs) generated from CAL27 and SCC-15 OSCC cells in the development of cisplatin (CDDP) resistance. We demonstrated that CSC_EVs enhance CDDP resistance, clonogenicity, and the tumorsphere formation potential of OSCC cells. Our bioinformatics analyses revealed that OSCC_EVs are enriched with microRNA (miR)-21-5p and are associated with increased metastasis, stemness, chemoresistance, and poor survival in patients with OSCC. Mechanistically, enhanced activity of CSC_EVs was positively correlated with upregulated β-catenin, phosphatidylinositol-3 kinase (PI3K), signal transducer and activator of transcription 3 (STAT3), mammalian target of rapamycin (mTOR), and transforming growth factor (TGF)-β1 messenger (m)RNA and protein expression levels. CSC_EVs also conferred a cancer-associated fibroblast (CAF) phenotype on normal gingival fibroblasts (NGFs), with the resultant CAFs enhancing the oncogenicity of OSCC cells. Interestingly, treatment with ovatodiolide (OV), the bioactive component of Anisomeles indica, suppressed OSCC tumorigenesis by reducing the cargo content of EVs derived from CSCs, suppressing self-renewal, and inhibiting the NGF-CAF transformation by disrupting EV-TME interactions. Moreover, by suppressing miR-21-5p, STAT3, and mTOR expressions in CSC_EVs, OV re-sensitized CSCs to CDDP and suppressed OSCC tumorigenesis. In vivo, treatment with OV alone or in combination with CDDP significantly reduced the tumor sphere-forming ability and decreased EV cargos containing mTOR, PI3K, STAT3, β-catenin, and miR-21-5p. In summary, our findings provide further strong evidence of OV’s therapeutic effect in OSCC." @default.
• W2997862810 created "2020-01-10" @default.
• W2997862810 creator A5005769924 @default.
• W2997862810 creator A5027712168 @default.
• W2997862810 creator A5036638776 @default.
• W2997862810 creator A5042195821 @default.
• W2997862810 creator A5060183326 @default.
• W2997862810 creator A5060391092 @default.
• W2997862810 creator A5064922397 @default.
• W2997862810 creator A5071664405 @default.
• W2997862810 creator A5076657463 @default.
• W2997862810 date "2019-12-24" @default.
• W2997862810 modified "2023-10-17" @default.
• W2997862810 title "Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts" @default.
• W2997862810 cites W2069104846 @default.
• W2997862810 cites W2091984900 @default.
• W2997862810 cites W2099111325 @default.
• W2997862810 cites W2111778115 @default.
• W2997862810 cites W2111915989 @default.
• W2997862810 cites W2119514671 @default.
• W2997862810 cites W2123242217 @default.
• W2997862810 cites W2129585918 @default.
• W2997862810 cites W2132834292 @default.
• W2997862810 cites W2151328979 @default.
• W2997862810 cites W2155542219 @default.
• W2997862810 cites W2161211430 @default.
• W2997862810 cites W2193861601 @default.
• W2997862810 cites W2343291871 @default.
• W2997862810 cites W2404284395 @default.
• W2997862810 cites W2581170516 @default.
• W2997862810 cites W2593959631 @default.
• W2997862810 cites W2604164345 @default.
• W2997862810 cites W2605544924 @default.
• W2997862810 cites W2726732890 @default.
• W2997862810 cites W2736977335 @default.
• W2997862810 cites W2742132023 @default.
• W2997862810 cites W2743022421 @default.
• W2997862810 cites W2749989670 @default.
• W2997862810 cites W2754749593 @default.
• W2997862810 cites W2758662787 @default.
• W2997862810 cites W2765293311 @default.
• W2997862810 cites W2772517487 @default.
• W2997862810 cites W2785291766 @default.
• W2997862810 cites W2789346654 @default.
• W2997862810 cites W2796995828 @default.
• W2997862810 cites W2799286552 @default.
• W2997862810 cites W2889434118 @default.
• W2997862810 cites W2895328436 @default.
• W2997862810 cites W2896178876 @default.
• W2997862810 cites W2900276526 @default.
• W2997862810 cites W2910371496 @default.
• W2997862810 cites W2911225106 @default.
• W2997862810 cites W2922323050 @default.
• W2997862810 cites W2923990740 @default.
• W2997862810 cites W2927452024 @default.
• W2997862810 cites W2936880972 @default.
• W2997862810 cites W2943315701 @default.
• W2997862810 cites W2943830014 @default.
• W2997862810 cites W2946053206 @default.
• W2997862810 cites W2946458410 @default.
• W2997862810 cites W2958880325 @default.
• W2997862810 cites W2964970137 @default.
• W2997862810 cites W2966087680 @default.
• W2997862810 doi "https://doi.org/10.3390/cancers12010056" @default.
• W2997862810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7017298" @default.
• W2997862810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31878245" @default.
• W2997862810 hasPublicationYear "2019" @default.
• W2997862810 type Work @default.
• W2997862810 sameAs 2997862810 @default.
• W2997862810 citedByCount "55" @default.
• W2997862810 countsByYear W29978628102020 @default.
• W2997862810 countsByYear W29978628102021 @default.
• W2997862810 countsByYear W29978628102022 @default.
• W2997862810 countsByYear W29978628102023 @default.
• W2997862810 crossrefType "journal-article" @default.
• W2997862810 hasAuthorship W2997862810A5005769924 @default.
• W2997862810 hasAuthorship W2997862810A5027712168 @default.
• W2997862810 hasAuthorship W2997862810A5036638776 @default.
• W2997862810 hasAuthorship W2997862810A5042195821 @default.
• W2997862810 hasAuthorship W2997862810A5060183326 @default.
• W2997862810 hasAuthorship W2997862810A5060391092 @default.
• W2997862810 hasAuthorship W2997862810A5064922397 @default.
• W2997862810 hasAuthorship W2997862810A5071664405 @default.
• W2997862810 hasAuthorship W2997862810A5076657463 @default.
• W2997862810 hasBestOaLocation W29978628101 @default.
• W2997862810 hasConcept C104317684 @default.
• W2997862810 hasConcept C121608353 @default.
• W2997862810 hasConcept C126322002 @default.
• W2997862810 hasConcept C145059251 @default.
• W2997862810 hasConcept C185592680 @default.
• W2997862810 hasConcept C2776107976 @default.
• W2997862810 hasConcept C2778923194 @default.
• W2997862810 hasConcept C2779013556 @default.
• W2997862810 hasConcept C3020616263 @default.
• W2997862810 hasConcept C31033888 @default.
• W2997862810 hasConcept C502942594 @default.
• W2997862810 hasConcept C55427017 @default.
• W2997862810 hasConcept C55493867 @default.

• next